2006
Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors
Mojsilovic-Petrovic J, Jeong GB, Crocker A, Arneja A, David S, Russell D, Kalb RG. Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors. Journal Of Neuroscience 2006, 26: 9250-9263. PMID: 16957081, PMCID: PMC6674510, DOI: 10.1523/jneurosci.1856-06.2006.Peer-Reviewed Original ResearchConceptsMotor neuronsAmyotrophic lateral sclerosisAdenosine A2A receptorsA2A receptorsBrain-derived neurotrophic factor (BDNF) activationReceptor tyrosine kinase BAbility of BDNFTyrosine kinase BMotor neuron diseaseSrc family kinasesAbnormal axonal transportFamilial motor neuron diseaseDirect kinase inhibitionExcitotoxic insultALS patientsNeuron diseaseAdenosine A2ALateral sclerosisTrk receptorsToxic insultsAxonal transportNeuronsInsultTransactivation pathwayFactor activation
1999
Repeated stress increases catalytic TrkB mRNA in rat hippocampus
Nibuya M, Takahashi M, Russell D, Duman R. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neuroscience Letters 1999, 267: 81-84. PMID: 10400217, DOI: 10.1016/s0304-3940(99)00335-3.Peer-Reviewed Original Research
1998
Differential Regulation of Neurotrophin and trkReceptor mRNAs in Catecholaminergic Nuclei during Chronic Opiate Treatment and Withdrawal
Numan S, Lane-Ladd S, Zhang L, Lundgren K, Russell D, Seroogy K, Nestler E. Differential Regulation of Neurotrophin and trkReceptor mRNAs in Catecholaminergic Nuclei during Chronic Opiate Treatment and Withdrawal. Journal Of Neuroscience 1998, 18: 10700-10708. PMID: 9852605, PMCID: PMC6793370, DOI: 10.1523/jneurosci.18-24-10700.1998.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBrain-Derived Neurotrophic FactorDrug Administration ScheduleDrug ImplantsGene Expression RegulationLocus CoeruleusMaleMesencephalonMorphineNerve Growth FactorsNeurotrophin 3RatsRats, Sprague-DawleyReceptor Protein-Tyrosine KinasesReceptor, Ciliary Neurotrophic FactorReceptor, trkCReceptors, Nerve Growth FactorRNA, MessengerTime FactorsVentral Tegmental AreaConceptsBrain-derived neurotrophic factorVentral tegmental areaChronic morphine treatmentChronic opiate treatmentLocus coeruleusHr of withdrawalMorphine treatmentNeurotrophin-3TrkC mRNAOpiate treatmentNeurotrophin brain-derived neurotrophic factorNT-3 mRNA expressionLevels of TrkBOpiate-induced plasticityTrkB mRNA levelsChronic morphine exposureNT-3 mRNATrkC mRNA levelsMRNA levelsEndogenous neurotrophinsExogenous neurotrophinsTrk mRNABDNF mRNAMorphine exposureTrkB mRNA